Top Markets
Coin of the day
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336
Rangering i aksjer #3341
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
Aksjekurs
$6.27
Markedsverdi
$5.62B
Endring (1 dag)
-0.46%
Endring (1 år)
26.35%
Land
CN
Handel Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

Kategori

Aksjeprishistorikk for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)
Høyeste sluttskurs: $6.78 den 2026-08-01

Laveste sluttskurs: $4.81 den 2020-07-01
Aksjeprishistorikk for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd fra 2020 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 5.66%
2025 188.76%
2024 -5.91%
2023 62.34%
2022 -30.84%
2021 -25.95%
2020 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$122.63 -12.26%
AU
$772.27 7.33%
CH